GeoVax Labs, Inc.
GOVX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000832489
No open-market purchases or sales by GeoVax Labs, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $625.5K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by GeoVax Labs, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for GeoVax Labs, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| McNally Robert T | Director | – | Jun 22, 2026 | 1 |
| Chase Randal D | Director | 36,613 | Jun 22, 2026 | 1 |
| Dodd David A | President, CEO | 36,661 | Jun 22, 2026 | 1 |
| Newman Mark J | Chief Scientific Officer | – | Jun 22, 2026 | 1 |
| Spencer John N Jr | Director | 21,402 | Jun 22, 2026 | 2 |
| Reynolds Mark | CFO | 14,013 | Jun 22, 2026 | 1 |
| Kollintzas Dean G | Director | – | Jun 22, 2026 | 1 |
| Sharkey John W. | VP, Business Development | 6,191 | Jun 22, 2026 | 1 |
| McKee Kelly T. Jr. | Chief Medical Officer | 3,494 | Jun 22, 2026 | 1 |
| Lemerond Nicole | Director | – | Jun 22, 2026 | 1 |
| Morgan Jayne | Director | – | Jun 22, 2026 | 1 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2025 (view filing) | Oct 17 | 3 days | Spencer John N JrDirector | PPurchase | +10.0K | $0.55 | +$5.50K | +87.7%21.4K after | |
| Aug 8, 2025 (view filing) | Aug 7 | 1 day | McKee Kelly T. Jr.Chief Medical Officer | PPurchase | +1.11K | $0.67 | +$741.69 | +46.4%3.49K after | |
| Apr 11, 2025 (view filing) | Apr 10 | 1 day | Spencer John N JrDirector | PPurchase | +10.0K | $0.98 | +$9.80K | +713.3%11.4K after | |
| Apr 10, 2025 (view filing) | Apr 10 | Same day | Sharkey John W.VP, Business Development | PPurchase | +6.00K | $0.99 | +$5.94K | +3,141.4%6.19K after | |
| Apr 1, 2025 (view filing) | Apr 1 | Same day | Dodd David APresident, CEO | PPurchase | +10.0K | $1.08 | +$10.8K | +37.5%36.7K after | |
| Mar 31, 2025 (view filing) | Mar 31 | Same day | Reynolds MarkCFO | PPurchase | +6.80K | $1.08 | +$7.34K | +94.3%14.0K after | |
| Aug 12, 2024 (view filing) | Aug 9 | 3 days | Dodd David APresident, CEO | PPurchase | +8.00K | $1.95 | +$15.6K | +42.9%26.7K after | |
| Feb 22, 2024 (view filing) | Feb 21-22 | 1 day | Dodd David APresident, CEO | PPurchase | +8.73K | $2.26 | +$19.8K | +87.9%18.7K after | 2 lots |
| Feb 7, 2024 (view filing) | Feb 7 | Same day | Reynolds MarkCFO | PPurchase | +2.00K | $2.77 | +$5.54K | +38.4%7.21K after | |
| Dec 26, 2023 (view filing)3:51 PM ET | Dec 22 | 4 days | McKee Kelly T. Jr.Chief Medical Officer | PPurchase | +6.94K | $0.36 | +$2.50K | +24.1%35.8K after | |
| Sep 27, 2023 (view filing) | Sep 25 | 2 days | McKee Kelly T. Jr.Chief Medical Officer | PPurchase | +9.65K | $0.52 | +$5.02K | +50.3%28.8K after | |
| Aug 28, 2023 (view filing) | Aug 25 | 3 days | Dodd David APresident, CEO | PPurchase | +35.1K | $0.57 | +$20.0K | +30.8%149.0K after | |
| Aug 21, 2023 (view filing) | Aug 18 | 3 days | Reynolds MarkCFO | PPurchase | +10.0K | $0.52 | +$5.20K | +14.7%78.2K after | |
| Apr 25, 2023 (view filing) | Apr 24 | 1 day | Dodd David APresident, CEO | PPurchase | +32.0K | $0.64 | +$20.5K | +39.1%113.9K after | |
| Apr 21, 2023 (view filing) | Apr 20 | 1 day | Reynolds MarkCFO | PPurchase | +8.00K | $0.63 | +$5.04K | +13.3%68.2K after | |
| Sep 23, 2022 (view filing) | Sep 21 | 2 days | Chase Randal DDirector | PPurchase | +10.0K | $1.10 | +$11.0K | +37.6%36.6K after | |
| Jul 5, 2022 (view filing) | Jul 1 | 4 days | Sharkey John W.VP, Business Development | PPurchase | +1.00K | $0.82 | +$820 | +53.8%2.86K after | |
| Jun 28, 2022 (view filing) | Jun 27 | 1 day | McKee Kelly T. Jr.Chief Medical Officer | PPurchase | +4.46K | $1.12 | +$5.00K | +30.3%19.2K after | |
| Jun 22, 2022 (view filing) | Jun 21 | 1 day | Chase Randal DDirector | PPurchase | +10.0K | $1.21 | +$12.1K | +60.2%26.6K after | |
| May 6, 2022 (view filing) | May 5 | 1 day | McKee Kelly T. Jr.Chief Medical Officer | PPurchase | +9.72K | $0.72 | +$7.00K | +194.5%14.7K after | |
| May 5, 2022 (view filing) | May 4 | 1 day | McKee Kelly T. Jr.Chief Medical Officer | PPurchase | +5.00K | $0.71 | +$3.55K | New position5.00K after |